Parkinson's disease

Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.

New research is unraveling the connection between the gut microbiome and Parkinson’s disease, revealing potential gut-targeted therapeutic strategies.

Exercise-induced molecules may inspire the next generation of neuroprotective drugs.

T cells that react to a Parkinson’s disease-linked protein have an early, unique, and detectable gene signature.

A biotech start-up teamed up with technology giants like Apple to continuously monitor people with Parkinson’s disease so that they could personalize their treatments in the clinic and the lab.

Exercise may improve cellular power plants gone haywire to ward off Parkinson’s disease. But researchers are still trying to understand how.

Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.

Art therapy improved brain connectivity in patients with Parkinson’s disease, suggesting that creating art may help treat it and other neurodegenerative diseases.

By fusing a brain-targeted antibody with an antibody that protects neurons from degeneration, scientists developed a new class of drugs that can traverse the blood brain barrier, enabling potential new treatments for Parkinson’s disease, Alzheimer’s disease, and depression.

A newly developed drug stabilizes dopamine and serotonin levels using a novel mechanism. It effectively treats psychosis in patients with schizophrenia, and researchers are testing its efficacy for Parkinson’s disease as well.